<DOC>
	<DOC>NCT00469456</DOC>
	<brief_summary>The objective of this study is to evaluate the effect of memantine versus placebo on functional communication in patients with Alzheimer's Disease</brief_summary>
	<brief_title>Effect of Memantine on Functional Communication in Patients With Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Male and female outpatients, 50 years or older, native English speakers, meeting National Institute of Neurological and Communicative Disorders and StrokeAlzheimer's Disease and Related Disorders Association (NINCDSADRDA) criteria for probable AD with a Mini Mental State Examination (MMSE) score of 10 to 19 at Screening and Baseline Current Diagnostic and Statistical Manual of Mental DisordersFourth Edition (DSMIV) Axis I disorder other than AD Previous imaging results not consistent with the diagnosis of AD Modified Hachinski Ischemia Score greater than 4 Evidence of other neurologic disorders Clinically significant systemic disease A known or suspected history of alcohol or drug abuse in the past 5 years Taking excluded medication Previous treatment with commercial memantine</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>memantine</keyword>
	<keyword>Alzheimer's Disease</keyword>
	<keyword>communication</keyword>
</DOC>